Dr. Nickols is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
15128 Vose St
Van Nuys, CA 91405Phone+1 818-421-5077
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Radiation Oncology, 2010 - 2014
University of California (Irvine)Internship, Internal Medicine, 2009 - 2010
David Geffen School of Medicine at UCLAClass of 2009
Certifications & Licensure
CA State Medical License 2010 - 2026- American Board of Radiology Radiation Oncology
Clinical Trials
- Systemic and Tumor-Directed Therapy for Oligometastatic Prostate Cancer Start of enrollment: 2018 Jul 01
- Antiandrogen Therapy and SBRT in Treating Patients With Recurrent, Metastatic Prostate Cancer Start of enrollment: 2021 Mar 17
Publications & Presentations
PubMed
- 32 citationsStereotactic Body Radiotherapy for High-Risk Localized Carcinoma of the Prostate (SHARP) Consortium: Analysis of 344 Prospectively Treated Patients.Ritchell van Dams, Naomi Y. Jiang, Donald B. Fuller, Andrew Loblaw, Tommy Jiang
International Journal of Radiation Oncology, Biology, Physics. 2021-01-23 - 213 citationsLong-term Outcomes of Stereotactic Body Radiotherapy for Low-Risk and Intermediate-Risk Prostate Cancer.Amar U. Kishan, Audrey Dang, Alan J. Katz, Constantine Mantz, Sean P. Collins
JAMA Network Open. 2019-02-01 - 14 citationsPhase 3 multicenter randomized trial of PSMA PET/CT prior to definitive radiation therapy for unfavorable intermediate-risk or high-risk prostate cancer [PSMA dRT]: st...Jeremie Calais, Shaojun Zhu, Nader Hirmas, Matthias Eiber, Boris Hadaschik
BMC Cancer. 2021-05-07
Press Mentions
Three UCLA/VA Researchers to Be Honored by Secretary of Veterans AffairsMay 4th, 2023- ‘STARPORT’ Trial Probes New Approach for Aggressive Prostate CancerAugust 16th, 2021
Assessment of 68Ga-PSMA-11 PET Accuracy in Localizing Recurrent Prostate Cancer: A Prospective Single-Arm Clinical TrialJune 1st, 2019- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
